NCT05958134View on ClinicalTrials.gov

Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

July 15, 2023

Primary Completion Date

June 6, 2024

Study Completion Date

June 6, 2024

Conditions
Diffuse Large B Cell Lymphoma
Trial Locations (4)

Unknown

Research Site, Belo Horizonte

Research Site, Recife

Research Site, Salvador

Research Site, São Paulo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Hospital Israelita Albert Einstein

OTHER

lead

AstraZeneca

INDUSTRY